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Dear Reader
As we approach the end of 2016, and publish our final issue of Drugs in R&D for the year, I wish to reflect on another
successful year for the journal and for others in the Adis Premier journals portfolio, and to thank all who have contributed
to Drugs in R&D over the past 12 months.
Mid-2016 saw the release of the ISI Journal Citation Reports and the latest journal impact factors. The majority of our
journals saw a rise in impact factor against the previous year. Most notably, five of our journals saw an increase of over
10% in impact factor—The Patient (17.08%), Clinical Drug Investigation (15.99%), the American Journal of Clinical
Dermatology (13.17%), Drug Safety (13.52%), and Drugs (12.43%).
Another important milestone was reached for our recently launched open access journals, Drug Safety—Case Reports
and Drugs—Real World Outcomes. Content from these journals is now available on PubMed Central.
The Adis journals portfolio will expand in 2017, with the launch of PharmacoEconomics—Open. This new journal will
be fully open access and will focus on the publication of applied research on the economic implications and health
outcomes associated with drugs, devices and other healthcare interventions. It joins our other well respected health
outcomes publications, PharmacoEconomics, Applied Health Economics and Health Policy, and The Patient: Patient-
Centered Outcomes Research.
I offer my sincere thanks to all authors who have contributed articles to Drugs in R&D over the course of 2016. Their
skill and dedication are critical to the continued publication of the journal. The quality of published articles is, similarly,
testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the
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In addition, I would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer
reviewers and authors, and have provided guidance on journal content, policy and processes:
G. An, University of Iowa, Iowa, IA, USA.
R. K. Campbell, Washington State University, Pullman,
WA, USA.
D. Cattaneo, Luigi Sacco University Hospital, Milan, Italy.
G. Cherala, Eastern Virginia Medical School, Norfolk, VA,
USA.
Y. K. Gupta, All India Institute of Medical Sciences, New
Delhi, India.
H. P. Hartung, Heinrich-Heine University, Dusseldorf,
Germany.
C. Ho¨cht, University of Buenos Aires, Buenos Aires,
Argentina.
N. M. Idkaidek, University of Petra, Amman, Jordan.
F. Jamali, University of Alberta, Edmonton, AB, Canada.
T. K. L. Kiang, The University of British Columbia,
Vancouver, BC, Canada.
M. J. McKeage, University of Auckland, Auckland, New
Zealand.
P. J. Nathan, Monash University, Melbourne, VIC,
Australia.
B. M. Patel, Nirma University, Ahmedabad, India.
S. Perez-Lloret, Institute for Cardiology Research, National
Research Council (ININCA-UBA-CONICET), Buenos
Aires, Argentina.
M. Pfister, University of Basel, Basel, Switzerland.
G. Remington, University of Toronto, Toronto, ON,
Canada.
H. Schu¨tz, BEBAC Consulting, Vienna, Austria.
M. H. Shishehbor, Cleveland Clinic Cardiovascular Dis-
ease, Cleveland, OH, USA.
L. P. Shulman, Feinberg School of Medicine of North-
western University, Chicago, IL, USA.
L. To´thfalusi, Semmelweis University, Budapest, Hungary.
R. Vats, Hyderabad Campus, Hyderabad, India.
J. Weiss, University of Heidelberg, Heidelberg, Germany.
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I hope that you have found the articles published throughout 2016 to be both interesting and informative. I have
appreciated the high quality of content contributed to the journal this year and I look forward to keeping you up to date with
topical issues in the R&D field in 2017.
With best wishes from Anton van Rensburg.
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you
give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were
made.
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